Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL9TK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,686
Award facts
- Contract value 100% obligated
- $13,685.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,685.75 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds significant responsibility for supplying critical pharmaceutical products and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to meet diverse medical procurement requirements through open competition, delivering brand-name and generic medications, vaccines, specialty treatments, and medical devices across multiple therapeutic domains. As the Defense Logistics Agency plans to establish its Pharmaceutical Prime Vendor Global Program Generation V with multiple regional awards, AmerisourceBergen's established track record positions it as a key supplier within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FL9TK?
SPE2DR26FL9TK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FL9TK worth?
The government has obligated $13,686 on SPE2DR26FL9TK.
Is contract SPE2DR26FL9TK an order under another contract?
Yes. SPE2DR26FL9TK is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9TK competed?
The extent of competition for SPE2DR26FL9TK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award